Should Cut-Off Values of the Risk of Malignancy Index be Changed for Evaluation of Adnexal Masses in Asian and Pacific Populations?

被引:9
作者
Yavuzcan, Ali [1 ]
Caglar, Mete [1 ]
Ozgu, Emre [2 ]
Ustun, Yusuf [1 ]
Dilbaz, Serdar [1 ]
Ozdemir, Ismail [3 ]
Yildiz, Elif [1 ]
Gungor, Tayfun [2 ]
Kumru, Selahattin [1 ]
机构
[1] Duzce Univ, Fac Med, Dept Obstet & Gynaecol, Duzce, Turkey
[2] Zekai Tahir Burak Womens Hlth Educ & Res Hosp, Dept Obstet & Gynaecol, Ankara, Turkey
[3] Medicana Int Istanbul Hosp, Dept Obstet & Gynaecol, Istanbul, Turkey
关键词
Adnexal mass; ovarian cancer; risk of malignancy index; PREOPERATIVE EVALUATION; OVARIAN MASSES; PELVIC MASSES; EXTERNAL VALIDATION; MENOPAUSAL STATUS; ULTRASOUND; DIAGNOSIS; CANCER; SURGERY; BENIGN;
D O I
10.7314/APJCP.2013.14.9.5455
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The risk of malignancy index (RMI) for the evaluation of adnexal masses is a sensitive tool in certain populations. The best cut off value for RMI 1, 2 and 3 is 200. The cut off value of RMI-4 to differentiate benign from malignant lesions is 450. Our aim was to evaluate the efficiency of four different malignancy indexes (RMI1-4) in a homogeneous population. Materials and Methods: We evaluated a total of 153 non-pregnant women with adnexal masses who did not have a history of malignancy and who were above 18 years of age. Results: A cut-off value of 250 for RMI-1 provided 95.9% inter-observer agreement, yielding 95.9% specificity, 93.5% negative predictive value, 75.0% sensitivity and 82.8% positive predictive value. A cut-off value of 250 for RMI-1 showed high performance in preoperative diagnosis of invasive malignant lesions than cut-off value of 200 in our population. A cut-off value of 350 for RMI-2 provided 94.5% inter-observed agreement, yielding 94.2% specificity, 93.4% negative predictive value, 75.0% sensitivity and 77.4% positive predictive value. RMI-2 showed the higher performance when the cut-off value was set at 350 in our population. A cut-off value of 250 provided 95.2% inter-observer agreement, yielding 95.0% specificity, 93.2% negative predictive value, 75.0% sensitivity, and 88.0% positive predictive value. RMI-3 showed the highest performance to diagnose malignant adnexal masses when the cut-off value was set at 250. In our study, RMI-4 showed similar statistical performance when the cut-off value was set at 400 [(Kappa: 0.684/p=0.000), yielding 93.8% inter-observer agreement, 93.4% specificity, 93.4% negative predictive value, 75.0% sensitivity, and 75.0% negative predictive value]. Conclusions: We showed successful utilization of RMIs in preoperative differentiation of benign from malignant masses. Many studies conducted in Asian and Pacific countries have reported different cut-off values as was the case in our study. We think that it is difficult to determine universally accepted cut-off values for RMIs for common use around the globe.
引用
收藏
页码:5455 / 5459
页数:5
相关论文
共 23 条
[1]   Comparison of four malignancy risk indices in the detection of malignant ovarian masses [J].
Akturk, Erhan ;
Karaca, Riza Efendi ;
Alanbay, Ibrahim ;
Dede, Murat ;
Karasahin, Emre ;
Yenen, Mufit Cemal ;
Baser, Iskender .
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2011, 22 (03) :177-182
[2]   IOTA simple rules for discriminating between benign and malignant adnexal masses: prospective external validation [J].
Alcazar, J. L. ;
Pascual, M. A. ;
Olartecoechea, B. ;
Graupera, B. ;
Auba, M. ;
Ajossa, S. ;
Hereter, L. ;
Julve, R. ;
Gaston, B. ;
Peddes, C. ;
Sedda, F. ;
Piras, A. ;
Saba, L. ;
Guerriero, S. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 42 (04) :467-471
[3]   Risk of Malignancy Index in the preoperative evaluation of patients with adnexal masses [J].
Andersen, ES ;
Knudsen, A ;
Rix, P ;
Johansen, B .
GYNECOLOGIC ONCOLOGY, 2003, 90 (01) :109-112
[4]  
Ashrafgangooei T, 2011, ASIAN PAC J CANCER P, V12, P1727
[5]   Risk of malignancy index for referral of ovarian cancer cases to a tertiary center: does it identify the correct cases? [J].
Bailey, J ;
Tailor, A ;
Naik, R ;
Lopes, A ;
Godfrey, K ;
Hatem, HM ;
Monaghan, J .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 :30-34
[6]  
Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209
[7]  
Berjapibal Mongkol, 2007, Journal of the Medical Association of Thailand, V90, P1986
[8]   Comparison of three malignancy risk indices and CA-125 in the preoperative evaluation of patients with pelvic masses [J].
Bouzari Z. ;
Yazdani S. ;
Ahmadi M.H. ;
Barat S. ;
Kelagar Z.S. ;
Kutenaie M.J. ;
Abbaszade N. ;
Khajat F. .
BMC Research Notes, 4 (1)
[9]   Requests for Tumor Marker Tests in Turkey Without Indications and Frequency of Elevation in Benign Conditions [J].
Cure, Medine Cumhur ;
Cure, Erkan ;
Kirbas, Aynur ;
Yazici, Tarkan ;
Yuce, Suleyman .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (12) :6485-6489
[10]   Factors influencing serum concentration of CA125 and CA15-3 in Iranian healthy postmenopausal women [J].
Dehaghani, Alamtaj Samsami ;
Ghiam, Alireza Fotouhi ;
Hosseini, Marjan ;
Mansouri, Sareh ;
Ghaderi, Abbas .
PATHOLOGY & ONCOLOGY RESEARCH, 2007, 13 (04) :360-364